Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase III subunit H (POLR3H) is a protein-coding subunit of the multi-protein RNA polymerase III complex, essential for the transcription of a variety of small non-coding RNAs including tRNAs, 5S rRNA, U6 snRNA, and other short RNAs fundamental to RNA maturation and cellular translation machinery. It is a peripheral part of the polymerase III complex, forms a mobile stalk (with CRCP/RPC9), and is crucial for transcription initiation. POLR3H also serves as a nuclear and cytosolic DNA sensor and plays a role in the innate immune system by detecting cytosolic non-self double-stranded DNA, which can trigger type I interferon and NF-κB signaling via the RIG-I pathway, particularly in response to certain viral infections. Mutations in POLR3H and other Pol III subunits are linked to tissue-specific genetic disorders including hypomyelinating leukodystrophy, cerebellar-retinal degeneration, and potentially increase susceptibility to some infections[1][2][3][6]. No direct pharmacological modulators or drugs targeting POLR3H are currently identified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase III subunit H (POLR3H).